{"log_id": 28165210488062164, "direction": 0, "words_result_num": 29, "words_result": [{"probability": {"variance": 0.029023, "average": 0.876325, "min": 0.431843}, "location": {"width": 1008, "top": 285, "height": 36, "left": 379}, "words": "两顶为湖!2周工期随机、安照剂对照、双育研究中,研究了710年龄5-10岁的"}, {"probability": {"variance": 0.034839, "average": 0.860297, "min": 0.359259}, "location": {"width": 1058, "top": 345, "height": 36, "left": 329}, "words": "儿科患者(486例服只托特罗定缓释校:224服用安慰剂),这些儿有尿频和急迫尿"}, {"probability": {"variance": 0.031461, "average": 0.877327, "min": 0.356819}, "location": {"width": 1058, "top": 404, "height": 36, "left": 326}, "words": "失症状。本品治疗中冰路兵占的比例(6.6%>高于安慰剂组(4.5%),不品治疗"}, {"probability": {"variance": 0.022708, "average": 0.911615, "min": 0.418554}, "location": {"width": 1063, "top": 466, "height": 34, "left": 322}, "words": "纽2.9%的患儿出现攻击性行为、异和多动行为或注意力碍,而安慰剂0.%的患儿有"}, {"probability": {"variance": 0.000193, "average": 0.98686, "min": 0.959788}, "location": {"width": 139, "top": 528, "height": 32, "left": 324}, "words": "这样的行为"}, {"probability": {"variance": 0.043266, "average": 0.854659, "min": 0.441752}, "location": {"width": 150, "top": 605, "height": 34, "left": 331}, "words": "【考年用药】"}, {"probability": {"variance": 0.017539, "average": 0.929829, "min": 0.42357}, "location": {"width": 1005, "top": 681, "height": 41, "left": 381}, "words": "托特罗定治疗的老年人和年轻人中,总体安全性上见差异见【药速理】的“临"}, {"probability": {"variance": 0.019422, "average": 0.90984, "min": 0.485863}, "location": {"width": 688, "top": 743, "height": 34, "left": 322}, "words": "床药学”,【药代动刀学】的特殊人群中的药代动力学\")"}, {"probability": {"variance": 0.014491, "average": 0.925168, "min": 0.674065}, "location": {"width": 203, "top": 825, "height": 36, "left": 329}, "words": "【药物互作用】"}, {"probability": {"variance": 0.027212, "average": 0.871503, "min": 0.421791}, "location": {"width": 989, "top": 903, "height": 36, "left": 379}, "words": "射西汀:西汀是选择性5-j色再抵取拟制剂,也是CYP26活性的强效抑割剂"}, {"probability": {"variance": 0.003922, "average": 0.972042, "min": 0.745187}, "location": {"width": 1060, "top": 960, "height": 38, "left": 322}, "words": "研评价了西汀对特罗定速释片及其代谢产物的药代动力学的影响结果发现在强代"}, {"probability": {"variance": 0.036024, "average": 0.866588, "min": 0.39573}, "location": {"width": 1060, "top": 1021, "height": 36, "left": 320}, "words": "谢者中,西打显孝制托特罗定速释片的代谢,使托罗定的AUC值升高8倍。托"}, {"probability": {"variance": 0.025115, "average": 0.906921, "min": 0.434277}, "location": {"width": 1058, "top": 1081, "height": 36, "left": 322}, "words": "罗定5-羟甲站代谢产物的C1降任52%,AUC值降低20%因此在对托特罗定速平片的强"}, {"probability": {"variance": 0.016868, "average": 0.927158, "min": 0.489435}, "location": {"width": 1053, "top": 1140, "height": 38, "left": 324}, "words": "代谢者中,西汀改变下托特罗定的药代动力学:蚀其药代动力学表现类低于在弱代谢者"}, {"probability": {"variance": 0.013194, "average": 0.934151, "min": 0.500426}, "location": {"width": 1056, "top": 1202, "height": 34, "left": 322}, "words": "中的表现。药物相互作用期闻,游离的托特罗定及其5-羟甲基代谢产物的血清浓度之和仅"}, {"probability": {"variance": 0.037721, "average": 0.829828, "min": 0.365272}, "location": {"width": 596, "top": 1262, "height": 36, "left": 317}, "words": "升商25%。托特罗定与氟西汀÷用时无需调剂量"}, {"probability": {"variance": 0.028453, "average": 0.867227, "min": 0.416638}, "location": {"width": 1005, "top": 1326, "height": 36, "left": 377}, "words": "经氧粪P450石酶代谢的他物:托特罗定这释片与经主要CYP酶类代的"}, {"probability": {"variance": 0.010988, "average": 0.933072, "min": 0.525764}, "location": {"width": 1058, "top": 1387, "height": 38, "left": 320}, "words": "其他药物合用,不引起有临末意义的药物相互作用。体内药物相互作用资显示,托特罗定"}, {"probability": {"variance": 0.027494, "average": 0.905969, "min": 0.365486}, "location": {"width": 1060, "top": 1447, "height": 36, "left": 320}, "words": "速释片不引起临床意义约对CYP1A212D6,2C9,2C19或3酶的制作用。证据是其"}, {"probability": {"variance": 0.026417, "average": 0.895786, "min": 0.403784}, "location": {"width": 1058, "top": 1506, "height": 38, "left": 320}, "words": "对标志药物咖啡因、喹L、S华法林及奥美拉研无明显影响。体外资料表明,打特罗定速"}, {"probability": {"variance": 0.023853, "average": 0.899006, "min": 0.50872}, "location": {"width": 1058, "top": 1566, "height": 34, "left": 320}, "words": "择片在高浓度时是CYP2D6的竞争性抑制剂(Ki1.0SμM),而托特罗定速片及其5-羟甲"}, {"probability": {"variance": 0.030673, "average": 0.900318, "min": 0.350015}, "location": {"width": 601, "top": 1627, "height": 36, "left": 322}, "words": "基谢产物对其他CYP同没有明显的抑作用"}, {"probability": {"variance": 0.035398, "average": 0.855354, "min": 0.373315}, "location": {"width": 1001, "top": 1691, "height": 36, "left": 377}, "words": " CRPS抑在8名健康志原者中研充了200mg1次的酮唑对托特罗赶"}, {"probability": {"variance": 0.020177, "average": 0.928221, "min": 0.361176}, "location": {"width": 1053, "top": 1751, "height": 36, "left": 322}, "words": "速释片药代动力学的影响,这名志愿者都是托转罗定的弱代者(参见【药代动力学】“代"}, {"probability": {"variance": 0.02694, "average": 0.893108, "min": 0.402326}, "location": {"width": 1060, "top": 1810, "height": 36, "left": 320}, "words": "谢的变异性“部分对弱代谢者的讨论)在有阻康咋的情况下:托特罗定的平均Crx和AUC"}, {"probability": {"variance": 0.030314, "average": 0.883587, "min": 0.432367}, "location": {"width": 1058, "top": 1870, "height": 38, "left": 320}, "words": "分别升高2倍和2.5倍。根据这些发现,其他CYPA4抑剖剂,如其他唑类抗真苗剂"}, {"probability": {"variance": 0.028103, "average": 0.854352, "min": 0.435757}, "location": {"width": 1028, "top": 1931, "height": 34, "left": 338}, "words": "划,伊曲床、咪康唑)、大环内酯类抗生素(如,红霉素、克拉霉素)、环孢素或长春"}, {"probability": {"variance": 0.036992, "average": 0.725104, "min": 0.530482}, "location": {"width": 178, "top": 2025, "height": 34, "left": 761}, "words": "笫石页,1页"}, {"probability": {"variance": 0.031407, "average": 0.783002, "min": 0.525699}, "location": {"width": 128, "top": 2062, "height": 25, "left": 404}, "words": "ia:2n13s02"}], "language": 3}